Navigation Links
Intrexon Announces Third Quarter Financial Results
Date:11/7/2013

ecognized during the period and includes the cash and stock received from collaborators for upfront and milestone payments during the period. We believe that adjusting for the impact of the change in deferred revenue in this manner is important since it permits us to make quarterly and annual comparisons of our ability to consummate new collaborations or to achieve significant milestones with existing collaborators. Further, we believe it is useful when evaluating our financial and operating performance, generating future operating plans and making strategic decisions about the allocation of capital.

Pro forma adjusted EBITDA per share.  Our calculations for pro forma adjusted EBITDA per share, basic and diluted, assumes, as of the end of the respective period, the conversion of all outstanding shares of our redeemable convertible preferred stock plus all cumulative dividends payable thereon into shares of common stock as if such conversion had occurred as of the later of (i) the beginning of the period or (ii) the issuance date of those shares.  Because all of our shares of redeemable convertible preferred stock and all accrued and cumulative dividends thereon automatically converted into common shares upon the closing of our initial public offering on August 13, 2013, we believe that the inclusion of such shares on an as-converted basis results in a useful metric for our investors, analysts and others when evaluating our results on a comparable basis with other periods.  While our management and board of directors believe that this non-GAAP per share metric is useful in evaluating our past adjusted EBITDA results, and may be of use to investors, analysts and others, this information should be considered supplemental in nature and is not meant as a substitute for the per share information prepared in accordance with GAAP.  In addition, this non-GAAP per share metric may not be the same as non-GAAP per share metrics presented by ot
'/>"/>

SOURCE Intrexon Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Soligenix and Intrexon Pursue Melioidosis Therapy Through Worldwide Exclusive Collaboration
2. Misonix, Inc. Announces First Quarter Fiscal Year 2014 Financial Results
3. Pro-Dex, Inc. Announces Fiscal 2014 First Quarter Financial Results Conference Call And Webcast
4. DURECT Announces Proposed Public Offering of Common Stock
5. Cellular Biomedicine Group Announces November 07, 2013 as Voting Deadline for Its Annual Shareholder Meeting
6. Star Scientific Announces Leadership Transition, Acceleration of Plans for Submission of an IND to FDA for Pharmaceutical Version of Anatabine Compound
7. Echo Therapeutics Announces Third Quarter 2013 Financial Results
8. Regado Biosciences, Inc. Announces Third Quarter 2013 Results
9. PDL BioPharma Announces Third Quarter 2013 Financial Results
10. Regulus Announces Timing for Third Quarter 2013 Financial Results Webcast and Conference Call
11. Heska Announces Financial Results for the Third Quarter of Fiscal 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... 2014 Companies that supply Durable Medical ... contact consumers directly about purchasing such supplies even ... The American Osteopathic Association,s House of Delegates voted ... companies that supply Durable Medical Equipment unless such ... physician and the patient. Typically ...
(Date:7/21/2014)... , July 21, 2014 ... Research titled, "Global biosimilars/follow-on-biologics market (types, applications and ... Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and ... biosimilars market would reach $35 billion by 2020 ... penetration with clearer regulatory pathways in developed markets ...
(Date:7/21/2014)... , July 21, 2014  PowerVision, Inc., ... fluid-based accommodating intraocular lens, today announced that ... and Law Chair of Ophthalmology, and Professor of ... the company,s Scientific Advisory Board. ... the American Academy of Ophthalmology Lifetime Achievement award, ...
Breaking Medicine Technology:American Osteopathic Association Calls for Eliminating Unsolicited Requests to Purchase Medical Equipment 2Biosimilars/Follow-on-Biologics Market is Expected to Reach $35 Billion, Globally, by 2020 2Biosimilars/Follow-on-Biologics Market is Expected to Reach $35 Billion, Globally, by 2020 3Biosimilars/Follow-on-Biologics Market is Expected to Reach $35 Billion, Globally, by 2020 4PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 2PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 3PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 4
... American Scientific Resources, Incorporated (OTCQB: ASFX) today announced ... containing results for the quarter ending March 31, ... review the entire 10-Q filing. (Logo: ... also like to direct investors to its corporate ...
... ANN ARBOR, Mich., May 24, 2011 ... long-term mechanical ventilation often require extensive additional care, ... A new study led by University ... chronic conditions who require long-term mechanical ventilation have ...
Cached Medicine Technology:American Scientific Resources, Inc. Announces Quarterly Results 2U-M Study: Children Dependent on Long-Term Mechanical Ventilation Require Longer, More Expensive Hospital Care 2U-M Study: Children Dependent on Long-Term Mechanical Ventilation Require Longer, More Expensive Hospital Care 3
(Date:7/22/2014)... (PRWEB) July 22, 2014 Industry-leading health ... announce the release of Specialty Pharmacy Trends and ... book that provides a comprehensive overview of the current ... includes management strategies and tactics for:, , ... cost and utilization concerns — including details of coinsurance ...
(Date:7/22/2014)... 2014 To help offset the typical ... Training Institute of Miami is reducing the cost ... model Brief Strategic Family Therapy™. To implement evidence-based ... variety of funding sources, but those opportunities seem to ... we want to help relieve somehow,” said the model ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Getting breast implants ... be completely optional or due to medical necessity. Either way, ... how to prepare for it, says Robert Kraft, MD, Plastic ... breast implant removal surgeries are performed each year in the ... But 70 percent of those procedures stem from three main ...
(Date:7/22/2014)... The hair transplant experts at WeGrowHair.com / ... laser therapy and robotic assisted hair transplantation to ... suffering from hair loss. Alongside their unique Multi-Unit ... Extraction (FUE) procedures via ARTAS – the world’s ... their doctors use advanced digital mapping to more ...
(Date:7/21/2014)... cancer cells could boost the effectiveness of chemotherapy to ... new study reports. , Scientists at The Institute of ... engineered version of the virus used to vaccinate against ... isolated limb perfusion chemotherapy given directly to blood ... alternative to amputation was more effective in rats ...
Breaking Medicine News(10 mins):Health News:Latest Edition of Annual Book Provides Comprehensive Overview of the Specialty Pharmacy Arena 2Health News:FTTIM Makes Brief Strategic Family Therapy Training a Little More Affordable 2Health News:FTTIM Makes Brief Strategic Family Therapy Training a Little More Affordable 3Health News:Is Breast Implant Removal Right for You? Plastic Surgeon Dr. Robert Kraft With Advanced Dermatology, PC Explains Breast Implant Removal and Offers Tips On Procedure 2Health News:Is Breast Implant Removal Right for You? Plastic Surgeon Dr. Robert Kraft With Advanced Dermatology, PC Explains Breast Implant Removal and Offers Tips On Procedure 3Health News:WeGrowHair.com/PAI Medical Group Introduces Robotic Assisted Laser Therapy to Treat Hair Loss 2Health News:Viral therapy could boost limb-saving cancer treatment 2Health News:Viral therapy could boost limb-saving cancer treatment 3
... sorafenib helps reverse disease resistance to anti-hormonal therapy ... drug sorafenib may help "re-sensitize" certain breast cancer ... Center researchers say. , Women with estrogen-receptor or ... cancers often take anti-hormonal medicines, such as aromatase ...
... hormone-receptor positive, metastatic breast cancer may take medications for ... when the tumor becomes resistant to anti-hormonal drugs, treatment ... presented today at the 2008 ASCO Breast Cancer Symposiummay ... treatment approach can "re-sensitize" the tumor, allowing anti-hormonal drugs ...
... York Fashion Week,s Annual Destination to Feature VelaShape. , ... ... http://www.americanlaser.com [American Laser Centers __title__ American Laser], the largest ... the U.S., announces sponsorship of the STYLE360 show during New York ...
... samples provided to physicians by pharmaceutical companies could actually ... according to a study done by researchers at Wake ... retrospective study looked at the prescribing habits of more ... in the months immediately before and after the closing ...
... 3, 2008In a case-control study, the presence of measles ... autism and GI disturbances than in children with only ... were unrelated to MMR vaccine timing. Study findings ... Science on September 4 ( http://dx.plos.org/10.1371/journal.pone.0003140 ). , ...
... Experts develop sequence of instructions they say could help doctors ... safety experts say that almost all kids who are allergic ... set of standard precautions. , Reporting in the September ... by the Johns Hopkins Children,s Center put forth a step-by-step ...
Cached Medicine News:Health News:Drug Re-Sensitizes Breast Tumors to Treatment 2Health News:1 step back ... 2 steps forward 2Health News:American Laser Centers Sponsors STYLE360 to Share the Skinny on Body Shaping 2Health News:Free drug samples may end up costing uninsured more 2Health News:Free drug samples may end up costing uninsured more 3Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 2Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 3Health News:Even Kids With Known Allergies Can Be Safely Vaccinated 2
An intermediate set providing a greater range of telescopes than the starter set....
Significantly more compact and tidier in overall looks yet retain many of the excellent features of the more comprehensive Haag type systems., ,Filters include Cobalt blue; green (red free); neut...
... up to 20 tilting ... in the vertical, horizontal ... the option to offset ... transillumination., ,Filters include Cobalt ...
With a high lens and filter range this ophthalmoscope is ideal for the Primary Care Specialist...
Medicine Products: